First Tracks Biotherapeutics Files Form 4
Ticker: TRAX · Form: 4 · Filed: Apr 23, 2026 · CIK: 0002091349
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
First Tracks Biotherapeutics filed a Form 4 on 4/23/26 for ownership changes.
AI Summary
On April 23, 2026, First Tracks Biotherapeutics, Inc. filed a Form 4, indicating changes in beneficial ownership of securities. The filing pertains to the period of report ending April 21, 2026. The document details transactions related to the company's securities.
Why It Matters
Form 4 filings disclose changes in stock ownership by company insiders, providing insights into their confidence in the company's prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of ownership changes and does not inherently indicate increased risk.
Key Players & Entities
- First Tracks Biotherapeutics, Inc. (company) — Issuer
- Ajim Tamboli (person) — Reporting Person
FAQ
What type of filing is this?
This is a Form 4 - Statement of changes in beneficial ownership of securities.
When was the filing accepted by the SEC?
The filing was accepted on 2026-04-23 at 18:08:54.
What is the CIK for First Tracks Biotherapeutics, Inc.?
The CIK for First Tracks Biotherapeutics, Inc. is 0002091349.
What is the period of report for this filing?
The period of report is 2026-04-21.
What is the business address listed for First Tracks Biotherapeutics, Inc.?
The business address listed is 10770 WATERIDGE CIRCLE SUITE 210 SAN DIEGO CA 92121.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 23, 2026 by Ajim Tamboli regarding First Tracks Biotherapeutics, Inc. (TRAX). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.